“We moved a lot, but I did most of my growing up outside Iowa City, Iowa,” Martin Myers says. His father was a physician, but his family lived on a farm that grew corn and soybeans. They had horses. He and his brother raised sheep. “We got up to no good,” he says. “Banging around […]
Read MoreCategory: Diabetes
Issues and Events
Issues and Events Source link
Read More
Introducing Diabetes, Obesity, and Cardiometabolic CARE with Alissa Segal, the ADA's Obesity Association & Standards of Care in Overweight and Obesity with Samar Hafida, and more!
With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast. The Points of CARE, the official podcast of Diabetes, Obesity, and Cardiometabolic CARE, will highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through interviews with journal authors and subject-matter […]
Read More
Special Edition – MASH Part 3- Cases Jan 2026
In this special series on Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated steatohepatitis (MASH) our host, Dr. Neil Skolnik will discuss diagnosis and treatment of MASH using a case-based approach with two master clinicians, one a hepatologist and the other a primary care physician. This special episode is supported by an independent educational […]
Read More
Special Edition – Oral GLP-1 Receptor Agonist
In this special series on Oral GLP-1 Receptor Agonists, Dr. Neil Skolnik will discuss the first of the GLP-1 RAs to receive FDA approval, Semaglutide. This special episode is supported by an independent educational grant from Novo. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; […]
Read More
Special Edition – AID Part 3- Cases Feb 2026
In this special series on Automated Insulin Delivery our host, Dr. Neil Skolnik will discuss with the benefits of Automated Insulin Delivery for people with Type 2 Diabetes with two master clinicians, one an diabetes specialist, the other a primary care doctor. This special episode is supported by an independent educational grant from Insulet. Presented […]
Read More
Special Edition – Weight Bias and Stigma – Part 2 – Jan 2026
In this special series on Weight Bias and Stigma our host, Dr. Neil Skolnik will discuss weight bias and stigma and its importance because weight bias and stigma have an important impact the experience of living with obesity, leads to measurable adverse outcomes, and when it is present in health care interactions it affects all […]
Read More
Diabetes Core Update Feb 2026
This issue will review: 1. Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial 2. Impact of Oral Semaglutide on Kidney Outcomes in People with Type 2 Diabetes: Results from the SOUL Randomized Trial 3. The effect of substituting water for artificially sweetened beverages on glycemic […]
Read MoreBaseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes
Abatacept, a cytotoxic T lymphocyte–associated protein 4 immunoglobulin that inhibits T-cell costimulation, was evaluated for 12 months in stage 1 type 1 diabetes (T1D) to delay disease progression. Despite modest preservation of area under the curve C-peptide at 12 months, the primary end point was not met. We adopted the oral minimal model (OMM) to […]
Read MoreProtection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion
Type 1 diabetes (T1D) is an autoimmune disease characterized by β-cell destruction promoted by autoreactive T cells. Eukaryotic translation initiation factor 4E (eIF4E)–binding protein 1 (4E-BP1) and 4E-BP2 are translational repressors and downstream targets of mammalian target of rapamycin complex 1 (mTORC1). Activation of the 4E-BP2/eIF4E pathway by 4E-BP2 deletion promotes translation initiation, inducing β-cell […]
Read More